SavedAdd your journal

Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2009 / Cilt: 19 - Sayı: 4

Does smoking amplify the risk of acute myocardial infarction related with pregnancy in factor V leiden carriers?

Mehmet YAZICI
Kadir ACAR
Mehmet KAYRAK
S. Selim AYHAN
Umuttan DOĞAN
Mehmet S. ÜLGEN
Pages
254–255
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

YAZICI, M., ACAR, K., KAYRAK, M., AYHAN, S. S., DOĞAN, U., ÜLGEN, M. S. (2009). Does smoking amplify the risk of acute myocardial infarction related with pregnancy in factor V leiden carriers?. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 19 - Sayı: 4, 254–255. https://ajindex.com/articles/322764

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153-68, 2003
  2. Martinelli I. Risk factor in venous thromboembolism. Thromb Haemost 86: 395-403, 2001
  3. Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol 16: 243-59, 2003
  4. Ginz B. Myocardial infarction in pregnancy. J Obstet Gynaecol Br Commonw 77: 610-15, 1970
  5. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 105: 480-4, 2005
  6. Kamineni R, Sadhu A, Alpert JS. Spontaneous coronary artery dissection: Report of two cases and 50-year review of the literature. Cardiol Rev 10: 279-284, 2002
  7. Agostoni P, Gasparini G, Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart 90: e12, 2004
  8. Rosendaal FR, Siscovick DS, Schwartz SM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89: 2817-21, 1997
  9. Barbash GI, White HD, Modan M, et al. Acute myocardial infarction in the young-the role of smoking. The Investigators of the International Tissue Plasminogen activator/Streptokinase Mortality Trial. Eur Heart J 16: 313-6, 1995.